{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:19:06Z","timestamp":1707524346844},"reference-count":29,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,11]]},"DOI":"10.7759\/cureus.17107","type":"journal-article","created":{"date-parts":[[2021,8,11]],"date-time":"2021-08-11T20:59:44Z","timestamp":1628715584000},"source":"Crossref","is-referenced-by-count":1,"title":["Improved Progression-Free Survival for Bulky and Non-Bulky Advanced Stage Diffuse Large B-Cell Lymphoma With Consolidative Radiation Therapy: A Bi-Institutional Analysis"],"prefix":"10.7759","author":[{"given":"Yusef A","family":"Syed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey","family":"Switchenko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khadija","family":"Kirmani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad K","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy K","year":"2013","unstructured":"Dunleavy K, Pittaluga S, Maeda LS, et al.. Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma. N Engl J Med. 2013, 368:1408-16. 10.1056\/NEJMoa1214561","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246","article-title":"Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte","volume":"116","author":"Coiffier B","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E, et al.. Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte. Blood. 2010, 116:2040-5. 10.1182\/blood-2010-03-276246","journal-title":"Blood"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.12.005","article-title":"Role of radiation therapy in patients with relapsed\/refractory diffuse large B-cell lymphoma: guidelines from the International Lymphoma Radiation Oncology Group","volume":"100","author":"Ng AK","year":"2018","unstructured":"Ng AK, Yahalom J, Goda JS, et al.. Role of radiation therapy in patients with relapsed\/refractory diffuse large B-cell lymphoma: guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2018, 100:652-69. 10.1016\/j.ijrobp.2017.12.005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4505","article-title":"Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma","volume":"32","author":"Held G","year":"2014","unstructured":"Held G, Murawski N, Ziepert M, et al.. Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. J Clin Oncol. 2014, 32:1112-8. 10.1200\/JCO.2013.51.4505","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.12.067","article-title":"Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging","volume":"84","author":"Dorth JA","year":"2012","unstructured":"Dorth JA, Prosnitz LR, Broadwater G, Diehl LF, Beaven AW, Coleman RE, Kelsey CR. Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging. Int J Radiat Oncol Biol Phys. 2012, 84:762-7. 10.1016\/j.ijrobp.2011.12.067","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000012104","article-title":"Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas","volume":"58","author":"Ferreri AJ","year":"2000","unstructured":"Ferreri AJ, Dell'Oro S, Reni M, Ceresoli GL, Cozzarini C, Ponzoni M, Villa E. Consolidation radiotherapy to bulky or semibulky lesions in the management of stage III-IV diffuse large B cell lymphomas. Oncology. 2000, 58:219-26. 10.1159\/000012104","journal-title":"Oncology"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3441","article-title":"Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy","volume":"28","author":"Phan J","year":"2010","unstructured":"Phan J, Mazloom A, Medeiros LJ, et al.. Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. J Clin Oncol. 2010, 28:4170-6. 10.1200\/JCO.2009.27.3441","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.02.007","article-title":"Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy","volume":"86","author":"Shi Z","year":"2013","unstructured":"Shi Z, Das S, Okwan-Duodu D, et al.. Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. Int J Radiat Oncol Biol Phys. 2013, 86:569-77. 10.1016\/j.ijrobp.2013.02.007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref9","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone PP","year":"1971","unstructured":"Carbone PP, Kaplan HS, Musshoff K, Smithers DW, Tubiana M. Report of the committee on Hodgkin's disease staging classification. Cancer Res. 1971, 31:1860-1.","journal-title":"Cancer Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","author":"International Non-Hodgkin's Lymphoma Prognostic Factors Project","year":"1993","unstructured":"International Non-Hodgkin's Lymphoma Prognostic Factors Project. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993, 329:987-94. 10.1056\/NEJM199309303291402","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2015.01.025","article-title":"Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation","volume":"92","author":"Jegadeesh N","year":"2015","unstructured":"Jegadeesh N, Rajpara R, Esiashvili N, et al.. Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation. Int J Radiat Oncol Biol Phys. 2015, 92:107-12. 10.1016\/j.ijrobp.2015.01.025","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.2403","article-title":"Revised response criteria for malignant lymphoma","volume":"25","author":"Cheson BD","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, et al.. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007, 25:579-86. 10.1200\/JCO.2006.09.2403","journal-title":"J Clin Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.08.2305","article-title":"Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma","volume":"25","author":"Juweid ME","year":"2007","unstructured":"Juweid ME, Stroobants S, Hoekstra OS, et al.. Use of positron emission tomography for response assessment of lymphoma: consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol. 2007, 25:571-8. 10.1200\/JCO.2006.08.2305","journal-title":"J Clin Oncol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(08)70078-0","article-title":"Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study","volume":"9","author":"Pfreundschuh M","year":"2008","unstructured":"Pfreundschuh M, Ho AD, Cavallin-Stahl E, et al.. Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study. Lancet Oncol. 2008, 9:435-44. 10.1016\/S1470-2045(08)70078-0","journal-title":"Lancet Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/s1470-2045(11)70235-2","article-title":"CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. The","volume":"12","author":"Pfreundschuh M","year":"2011","unstructured":"Pfreundschuh M, Kuhnt E, Trumper L, et al.. CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MInT) Group. The. Lancet Oncol. 2011, 12:1013-22. 10.1016\/s1470-2045(11)70235-2","journal-title":"Lancet Oncol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma","volume":"346","author":"Coiffier B","year":"2002","unstructured":"Coiffier B, Lepage E, Briere J, et al.. CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma. N Engl J Med. 2002, 346:235-42. 10.1056\/NEJMoa011795","journal-title":"N Engl J Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200211002-00007","article-title":"Aggressive lymphoma: improving treatment outcome with rituximab","volume":"13 Suppl 2","author":"Coiffier B","year":"2002","unstructured":"Coiffier B, Pfreundschuh M, Stahel R, Vose J, Zinzani PL. Aggressive lymphoma: improving treatment outcome with rituximab. Anticancer Drugs. 2002, 13 Suppl 2:S43-50. 10.1097\/00001813-200211002-00007","journal-title":"Anticancer Drugs"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29113","article-title":"Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project","volume":"121","author":"Dabaja BS","year":"2015","unstructured":"Dabaja BS, Vanderplas AM, Crosby-Thompson AL, et al.. Radiation for diffuse large B-cell lymphoma in the rituximab era: analysis of the National Comprehensive Cancer Network lymphoma outcomes project. Cancer. 2015, 121:1032-9. 10.1002\/cncr.29113","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.8041","article-title":"Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: a subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA)","volume":"38","author":"Held G","year":"2020","unstructured":"Held G, Thurner L, Poeschel V, et al.. Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: a subgroup analysis of the unfolder trial of the German Lymphoma Alliance (GLA). J Clin Oncol. 2020, 38:8041. 10.1200\/JCO.2020.38.15_suppl.8041","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.35.15_suppl.7506","article-title":"Radiotherapy to bulky disease PET-negative after immunochemotherapy in elderly DLBCL patients: results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL>60 study of the DSHNHL","volume":"35","author":"Pfreundschuh M","year":"2017","unstructured":"Pfreundschuh M, Christofyllakis K, Altmann B, et al.. Radiotherapy to bulky disease PET-negative after immunochemotherapy in elderly DLBCL patients: results of a planned interim analysis of the first 187 patients with bulky disease treated in the OPTIMAL>60 study of the DSHNHL. J Clin Oncol. 2017, 35:7506. 10.1200\/JCO.2017.35.15_suppl.7506","journal-title":"J Clin Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-766691","article-title":"FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study","volume":"130","author":"Casasnovas RO","year":"2017","unstructured":"Casasnovas RO, Ysebaert L, Thieblemont C, et al.. FDG-PET-driven consolidation strategy in diffuse large B-cell lymphoma: final results of a randomized phase 2 study. Blood. 2017, 130:1315-26. 10.1182\/blood-2017-02-766691","journal-title":"Blood"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199807023390104","article-title":"Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma","volume":"339","author":"Miller TP","year":"1998","unstructured":"Miller TP, Dahlberg S, Cassady JR, et al.. Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. N Engl J Med. 1998, 339:21-6. 10.1056\/NEJM199807023390104","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042040","article-title":"ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma","volume":"352","author":"Reyes F","year":"2005","unstructured":"Reyes F, Lepage E, Ganem G, et al.. ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. N Engl J Med. 2005, 352:1197-205. 10.1056\/NEJMoa042040","journal-title":"N Engl J Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.06.088","article-title":"Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484","volume":"22","author":"Horning SJ","year":"2004","unstructured":"Horning SJ, Weller E, Kim K, Earle JD, O'Connell MJ, Habermann TM, Glick JH. Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. J Clin Oncol. 2004, 22:3032-8. 10.1200\/JCO.2004.06.088","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.07.0722","article-title":"CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte","volume":"25","author":"Bonnet C","year":"2007","unstructured":"Bonnet C, Fillet G, Mounier N, et al.. CHOP alone compared with CHOP plus radiotherapy for localized aggressive lymphoma in elderly patients: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol. 2007, 25:787-92. 10.1200\/JCO.2006.07.0722","journal-title":"J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-12-288","article-title":"Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis","volume":"12","author":"dos Santos LV","year":"2012","unstructured":"dos Santos LV, Lima JP, Lima CS, Sasse EC, Sasse AD. Is there a role for consolidative radiotherapy in the treatment of aggressive and localized non-Hodgkin lymphoma? A systematic review with meta-analysis. BMC Cancer. 2012, 12:288. 10.1186\/1471-2407-12-288","journal-title":"BMC Cancer"},{"key":"ref27","article-title":"Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?","volume":"24","author":"Kelsey CR","year":"2010","unstructured":"Kelsey CR, Beaven AW, Diehl LF, Prosnitz LR. Radiation therapy in the management of diffuse large B-cell lymphoma: still relevant?. Oncology (Williston Park). 2010, 24:1204-12.","journal-title":"Oncology (Williston Park)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.4103\/0971-3026.125626","article-title":"FDG-PET\/CT in lymphoma","volume":"23","author":"D'souza MM","year":"2013","unstructured":"D'souza MM, Jaimini A, Bansal A, Tripathi M, Sharma R, Mondal A, Tripathi RP. FDG-PET\/CT in lymphoma. Indian J Radiol Imaging. 2013, 23:354-65. 10.4103\/0971-3026.125626","journal-title":"Indian J Radiol Imaging"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229","article-title":"Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group","volume":"32","author":"Barrington SF","year":"2014","unstructured":"Barrington SF, Mikhaeel NG, Kostakoglu L, et al.. Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol. 2014, 32:3048-58. 10.1200\/JCO.2013.53.5229","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/61498-improved-progression-free-survival-for-bulky-and-non-bulky-advanced-stage-diffuse-large-b-cell-lymphoma-with-consolidative-radiation-therapy-a-bi-institutional-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:29:19Z","timestamp":1707506959000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/61498-improved-progression-free-survival-for-bulky-and-non-bulky-advanced-stage-diffuse-large-b-cell-lymphoma-with-consolidative-radiation-therapy-a-bi-institutional-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,11]]},"references-count":29,"URL":"https:\/\/doi.org\/10.7759\/cureus.17107","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8,11]]}}}